BTD
GILD icon

BankPlus Trust Department’s Gilead Sciences GILD Stock Holding History

BankPlus Trust Department’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85K Sell
610
-40
-6% -$5.6K 0.02% 229
2025
Q4 		$79.8K Hold
650
– – 0.02% 227
2025
Q3 		$72.2K Hold
650
– – 0.02% 229
2025
Q2 		$72.1K Buy
650
+500
+333% +$53.2K 0.02% 212
2025
Q1 		$16.8K Sell
150
-35
-19% -$3.61K 0.01% 321
2024
Q4 		$17.1K Buy
+185
New +$16.7K 0.01% 304

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BankPlus Trust Department's GILD Position: Q1 2026 in Review

BankPlus Trust Department reduced its Gilead Sciences (GILD) stake by 6.2% in Q1 2026, selling an estimated $5.6K and leaving 610 shares worth $85K. The position accounts for 0.02% of the portfolio, ranked #229.

BankPlus Trust Department first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • BankPlus Trust Department held 610 shares of Gilead Sciences worth $85K as of Q1 2026.
  • BankPlus Trust Department sold 40 Gilead Sciences shares in Q1 2026, an estimated $5.6K.
  • Gilead Sciences made up 0.02% of BankPlus Trust Department's portfolio in Q1 2026, its #229 holding.
  • BankPlus Trust Department first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on BankPlus Trust Department's 13F filing for Q1 2026, filed 11 May 2026.